Company Mabvax Therapeutics Holdings Inc Nasdaq
Equities
US55414P5044
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 14-07-07 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 14-07-07 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 14-07-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 33,333 | 0 | 0 | 92.02 % |
Stock B | 0 | 44,104 | 0 | 0 | |
Stock C | 1 | 9,429,582 | 8,677,104 ( 92.02 %) | 0 |
Company contact information
MabVax Therapeutics Holdings, Inc.
559 Evans Mountain Road
72031, Clinton
+858-259-9405
Sector
1st Jan change | Capi. | |
---|---|---|
+9.43% | 114B | |
+11.55% | 104B | |
-14.07% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.03% | 17.89B | |
+6.85% | 14.28B | |
+35.45% | 12.55B |